KAWAKAMI MARK (Chief Financial Officer) purchased 54.6% of their position (700.00 shares) of ARCADIA BIOSCIENCES, INC. on the open market
Open‑market purchase worth $1.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/20/2024ACC: 0000950170-24-099338
Officer· Chief Financial Officer
Since Jul 2024
+700.00
Net shares
Net buyer
$1.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
700.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+700.00
Price / share
$2.06
Trade value
$1.44K
% of position
54.6%
8/1/2024
1.28K→1.98K
Total
Net shares
+700.00
Net value
$1.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2024 | P · Purchase | +700.00 | $2.06 | $1.44K | 54.6% | 1.28K | 1.98K |
| Total | +700.00 | $1.44K | ||||||
Derivative Transactions0
No derivative transactions reported